Effect of Myofunctional Therapy on OSA
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- San Diego, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 209 people enrolled
- Started
- 2 Aug 2021
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- OMT Exercises
- Nasal Breathing Exercises
- Use of Nasal Lavage
- Record updated
- 8 January 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Mild-to-moderate OSA
- Entry criteria are as inclusive as possible and operationalized as follows: age>18 years old
- Confirmed diagnosis of OSA
- Having chronic symptoms per screening symptom checklist
- Fluency in English
- Must be getting care the VA San Diego Healthcare System
Who cannot take part
- Cognitive impairment sufficient to cause inability to complete the protocol (per medical chart review)
- Low health literacy
- Residence in a geographical area outside of San Diego County
- Fatal comorbidity (life expectancy <6 months as indicated by treating physician)
- Significant documented substance/chemical abuse
Where in United States
- VA San Diego Healthcare System, San Diego, CASan Diego, United States
About the trial
What the trial wants to find out
The primary medical therapies for patients with Obstructive Sleep Apnea syndrome (OSA) require the use of medical devices on a nightly basis to help control breathing during sleep, which can be difficult for patients with mild-to-moderate disease. Because many patients use these therapies on a limited basis, or stop using them altogether, they continue to be at increased risk of the consequences of untreated OSA. Untreated and undertreated OSA compounds the risk of OSA consequences over time, particularly with increasing age and weight. Orofacial Myofunctional Therapy (OMT) takes a rehabilitative approach to OSA and is comprised of isotonic and isometric exercises that target the oral (e.g., tongue) and oropharyngeal (e.g., soft palate, lateral pharyngeal wall) to help restore normal breathing and airway patency at night while asleep. Should the study have positive findings, OMT could become an important alternative therapy for patients with mild-to-moderate disease because patients could utilize a therapy that improves their nighttime breathing through daytime exercises and without the need for a burdensome medical device.
The 2 groups in the trial
- Active Myofunctional TherapyExisting treatment, for comparison
Active Myofunctional Therapy is comprised of five 30-minute weekly sessions for 4 weeks.
Treatment: OMT Exercises
- Inactive Myofunctional TherapySham treatment, for comparison
Sham MT will be comprised of recommendations for five 30-minute nasal breathing exercises each week, use of nasal lavage with application of 10ml of saline in each nostril two times per day.
Treatment: Nasal Breathing Exercises and Use of Nasal Lavage
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Myofunctional Therapy on Outcomes in Mild to Moderate Sleep Apnea
- Record updated
- 8 January 2026